UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics

mAbs, 2021-01, Vol.13 (1), p.1982447-1982447

2021

Volltextzugriff (PDF)

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

Molecular therapy. Oncolytics, 2017-03, Vol.4 (C), p.77-86

2017

Volltextzugriff (PDF)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16018-16018, Article 16018

2016

Volltextzugriff (PDF)

Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells: Oncolytic adenoviruses for MSC delivery to pancreatic cancer

International journal of cancer, 2015-08, Vol.137 (4), p.978-990

2015

Volltextzugriff (PDF)

Genetic delivery of an immuno RN ase by an oncolytic adenovirus enhances anticancer activity

International journal of cancer, 2015-05, Vol.136 (9), p.2228-2240

2015

Volltextzugriff (PDF)

Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis: Gene Regulation for Effective Gene Therapy

Advanced drug delivery reviews, 2009, Vol.61 (7-8), p.554-571

2009

Volltextzugriff (PDF)

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: R esults in vitro , in rodents and in humans

International journal of cancer, 2015-10, Vol.137 (7), p.1775-1783

2015

Volltextzugriff (PDF)

Abstract B063: Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive T cell therapy of solid tumors

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.B063-B063

2016

Volltextzugriff (PDF)

Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Cancer immunology research, 2015-10, Vol.3 (10_Supplement), p.B51-B51

2015

Volltextzugriff (PDF)

Nucleic Acid Transfer

Handbook of Dendritic Cells, 2006, p.1143-1171

2006

Volltextzugriff (PDF)

Evaluation of E1A Double Mutant Oncolytic Adenovectors in Anti-Glioma Gene Therapy

Journal of medical virology, 2008-09, Vol.80 (9), p.1595-1603

2008

Volltextzugriff (PDF)

Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft Tissue Sarcoma

Human gene therapy, 2006-12, p.61222090124001

2006

Volltextzugriff (PDF)

Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft tissue Sarcoma

Human gene therapy, 2006-12, p.61221065408001

2006

Volltextzugriff (PDF)

620. A Longer Human Telomerase Reverse Transcriptase Promoter-Based Conditionally Replicative Adenovirus Shows Oncolysis with Less Toxicity for Ovarian Cancer Treatment

Molecular therapy, 2004-05, Vol.9 (S1), p.S235-S235

2004

Volltextzugriff (PDF)

970. A Fiber Modified SLPI Promoter Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer

Molecular therapy, 2004-05, Vol.9 (S1), p.S371-S371

2004

Volltextzugriff (PDF)

Tumor-Busting Viruses

Scientific American sp, 2008-07, Vol.18 (3), p.72-79

2008

Volltextzugriff (PDF)

Mit Viren gegen Krebs

Spektrum der Wissenschaft, 2004 (7), p.24-31

2004

Volltextzugriff (PDF)

Promoter Optimization and Artificial Promoters for Transcriptional Targeting in Gene Therapy

Vector Targeting for Therapeutic Gene Delivery, 2002, p.481-503

2002

Volltextzugriff (PDF)

Tumor-Busting Viruses: A new technique called virotherapy harnesses viruses, those banes of humankind, to stop another scourge--cancer

Scientific American, 2003-10, Vol.289 (4), p.None

Dirk M. Nettelbeck and David T. Curiel

2003

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Sprache

Englisch
(18)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics

Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses

Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells: Oncolytic adenoviruses for MSC delivery to pancreatic cancer

Genetic delivery of an immuno RN ase by an oncolytic adenovirus enhances anticancer activity

Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis: Gene Regulation for Effective Gene Therapy

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM‐CSF: R esults in vitro , in rodents and in humans

Abstract B063: Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive T cell therapy of solid tumors

Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

Nucleic Acid Transfer

Evaluation of E1A Double Mutant Oncolytic Adenovectors in Anti-Glioma Gene Therapy

Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft Tissue Sarcoma

Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft tissue Sarcoma

620. A Longer Human Telomerase Reverse Transcriptase Promoter-Based Conditionally Replicative Adenovirus Shows Oncolysis with Less Toxicity for Ovarian Cancer Treatment

970. A Fiber Modified SLPI Promoter Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer

Tumor-Busting Viruses

Mit Viren gegen Krebs

Promoter Optimization and Artificial Promoters for Transcriptional Targeting in Gene Therapy

Tumor-Busting Viruses: A new technique called virotherapy harnesses viruses, those banes of humankind, to stop another scourge--cancer

Aktive Filter

Suchergebnisse filtern